In addition to numerous retrospective studies reporting on improved macular edema and central macular thickness (CMT) after the use of anti-VEGF therapy, several key prospective studies have shown statistically significant improvement in BCVA after regularly injecting intravitreal anti-VEGF. The gene discussed is VEGFA; the disease is macular retinal edema.